| Neuroblastoma: developmental biology, cancer genomics and immunotherapy NKV Cheung, MA Dyer Nature Reviews Cancer 13 (6), 397-411, 2013 | 919 | 2013 |
| Mechanism by which orally administered β-1, 3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models F Hong, J Yan, JT Baran, DJ Allendorf, RD Hansen, GR Ostroff, PX Xing, ... The Journal of Immunology 173 (2), 797-806, 2004 | 659 | 2004 |
| Radioimmunotherapy of human tumours SM Larson, JA Carrasquillo, NKV Cheung, OW Press Nature Reviews Cancer 15 (6), 347-360, 2015 | 553 | 2015 |
| Association of age at diagnosis and genetic mutations in patients with neuroblastoma NKV Cheung, J Zhang, C Lu, M Parker, A Bahrami, SK Tickoo, A Heguy, ... Jama 307 (10), 1062-1071, 2012 | 523 | 2012 |
| Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. NK Cheung, H Lazarus, FD Miraldi, CR Abramowsky, S Kallick, ... Journal of clinical oncology 5 (9), 1430-1440, 1987 | 497 | 1987 |
| Malignant pheochromocytoma: current status and initiatives for future progress G Eisenhofer, SR Bornstein, FM Brouwers, NKV Cheung, PL Dahia, ... Endocrine-related cancer 11 (3), 423-436, 2004 | 474 | 2004 |
| Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes A Krause, HF Guo, JB Latouche, C Tan, NKV Cheung, M Sadelain The Journal of experimental medicine 188 (4), 619-626, 1998 | 448 | 1998 |
| Association of CYP3A4 genotype with treatment-related leukemia CA Felix, AH Walker, BJ Lange, TM Williams, NJ Winick, NKV Cheung, ... Proceedings of the National Academy of Sciences 95 (22), 13176-13181, 1998 | 446 | 1998 |
| Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. BH Kushner, MP LaQuaglia, N Wollner, PA Meyers, KL Lindsley, ... Journal of Clinical Oncology 14 (5), 1526-1531, 1996 | 416 | 1996 |
| Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells NKV Cheung, UM Saarinen, JE Neely, B Landmeier, D Donovan, ... Cancer research 45 (6), 2642-2649, 1985 | 413 | 1985 |
| The ALKF1174L mutation potentiates the oncogenic activity of MYCN in neuroblastoma T Berry, W Luther, N Bhatnagar, Y Jamin, E Poon, T Sanda, D Pei, ... Cancer cell 22 (1), 117-130, 2012 | 393 | 2012 |
| Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura JB Bussel, RP Kimberly, RD Inman, I Schulman, C Cunningham-Rundles, ... | 382 | 1983 |
| MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors H Xu, IY Cheung, HF Guo, NKV Cheung Cancer research 69 (15), 6275-6281, 2009 | 362 | 2009 |
| Characteristics of stem cells from human neuroblastoma cell lines and in tumors JD Walton, DR Kattan, SK Thomas, BA Spengler, HF Guo, JL Biedler, ... Neoplasia 6 (6), 838-845, 2004 | 310 | 2004 |
| Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients … NKV Cheung, IY Cheung, BH Kushner, I Ostrovnaya, E Chamberlain, ... Journal of clinical oncology 30 (26), 3264-3270, 2012 | 285 | 2012 |
| Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment N Tarek, JB Le Luduec, MM Gallagher, J Zheng, JM Venstrom, ... The Journal of clinical investigation 122 (9), 3260-3270, 2012 | 272 | 2012 |
| Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma K Kramer, BH Kushner, S Modak, N Pandit-Taskar, P Smith-Jones, ... Journal of neuro-oncology 97, 409-418, 2010 | 265 | 2010 |
| Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies NKV Cheung, S Modak, A Vickers, B Knuckles Cancer Immunology, Immunotherapy 51, 557-564, 2002 | 262 | 2002 |
| Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial MM Souweidane, K Kramer, N Pandit-Taskar, Z Zhou, S Haque, ... The Lancet Oncology 19 (8), 1040-1050, 2018 | 256 | 2018 |
| Anti-G (D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. NK Cheung, BH Kushner, IY Cheung, K Kramer, A Canete, W Gerald, ... Journal of clinical oncology 16 (9), 3053-3060, 1998 | 250 | 1998 |
